Get started
Author

Mary F. Dillon

The Accuracy of Ultrasound, Stereotactic, and Clinical Core Biopsies in the Diagnosis of Breast Cancer, With an Analysis of False-Negative Cases
2005 · Mary F. Dillon, Arnold D. K. Hill, et al. · Annals of Surgery · 129
A Pathologic Assessment of Adequate Margin Status in Breast-Conserving Therapy
2006 · Mary F. Dillon, Arnold D. K. Hill, et al. · Annals of Surgical Oncology · 122
Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only
2006 · Mary F. Dillon, Enda W. McDermott, et al. · Journal of Surgical Oncology · 104
Factors Affecting Successful Breast Conservation for Ductal Carcinoma in Situ
2007 · Mary F. Dillon, Enda W. Mc Dermott, et al. · Annals of Surgical Oncology · 95
Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence
2009 · Aisling M. Redmond, Fiona T. Bane, et al. · Clinical Cancer Research · 91
Predictive Value of Breast Lesions of “Uncertain Malignant Potential” and “Suspicious for Malignancy” Determined by Needle Core Biopsy
2006 · Mary F. Dillon, Enda W. McDermott, et al. · Annals of Surgical Oncology · 85
Needle core biopsy in the diagnosis of phyllodes neoplasm
2006 · Mary F. Dillon, Cecily M. Quinn, et al. · Surgery · 84
Analysis of patients with false negative mammography and symptomatic breast carcinoma
2007 · Ian G. Murphy, Mary F. Dillon, et al. · Journal of Surgical Oncology · 60
Preoperative Characteristics Identify Patients with Hip Fractures at Risk of Transfusion
2005 · Mary F Dillon, Denis Collins, et al. · Clinical Orthopaedics and Related Research · 58
The role of major duct excision and microdochectomy in the detection of breast carcinoma
2006 · Mary F Dillon, Shah R Mohd Nazri, et al. · BMC Cancer · 47
PDF
Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma
2006 · Mary F. Dillon, Arnold D.K. Hill, et al. · The American Journal of Surgery · 46
Needle core biopsy characteristics identify patients at risk of compromised margins in breast conservation surgery
2007 · Mary F Dillon, Aoife A Maguire, et al. · Modern Pathology · 34
PDF
Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients
2008 · M. F Dillon, A. T Stafford, et al. · Endocrine Related Cancer · 33
PDF
Acid suppression increases rates of Barrett’s esophagus and esophageal injury in the presence of duodenal reflux
2011 · Ayman O. Nasr, Mary F. Dillon, et al. · Surgery · 23
The Value of Level III Clearance in Patients With Axillary and Sentinel Node Positive Breast Cancer
2009 · Mary F. Dillon, Vriti Advani, et al. · Annals of Surgery · 9
The Extent of Axillary Lymph Node Clearance Required Following Detection of Sentinel Node Micrometastases
2010 · Mary F. Dillon, Brian D. Hayes, et al. · The Breast Journal · 1
Management of B3 Lesions and Breast Biopsies
2008 · Mary F. Dillon, Enda W. Mc Dermott, et al. · Annals of Surgical Oncology · 1
Data from Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence
2023 · Aisling M. Redmond, Fiona T. Bane, et al.
Data from Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence
2023 · Aisling M. Redmond, Fiona T. Bane, et al.
Supplementary Figure S1 from Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence
2023 · Aisling M. Redmond, Fiona T. Bane, et al.
Antibody-based biosensor assays for the detection of zilpaterol and markers for prostate cancer
2008 · Mary F. Dillon · Arrow@dit (Dublin Institute of Technology)
PDF
Works count: 21
Citation count: 1,022
H-index: 14
I10-index: 14
Year
Topic
Type